Host-Response Diagnostics

Delivering precision medicine on demand


TEDx Palo Alto:
The power of reading the immune system to better diagnose disease

Dr. Tim Sweeney, Inflammatix Co-Founder and CEO

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people


In the News: Game Changing Impact

Recent notable news stories

April 22, 2020

The Life Science Sector Shifts Its Focus Quickly to Respond to the Coronavirus

Link to story

April 1, 2020

The Battle for a Better Sepsis Test

Link to story

March 9, 2020

Inflammatix named to Fierce 15 MedTech list

Link to story

January 10, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Link to story

Also covered by


Stay in touch with Twitter updates: Find out the latest news.

Connect with Twitter